| Serial Number | 79418922 |
| Word Mark | P5 |
| Filing Date | Thursday, February 6, 2025 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, March 10, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 10, 2026 |
| Pseudo Mark | P 5 |
| Pseudo Mark | P FIVE |
| Goods and Services | Scientific and technological services, namely scientific research, analysis, testing and design in the fields of biology, chemistry and medicine, as well as in the fields of immunology, oncology, molecular biology, cellular biology, biochemistry and medicinal chemistry as well as in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, diagnostic preparations, biomarker reagents and diagnostic apparatus |
| Goods and Services | Chemical, biochemical, biological, and biotechnological preparations, in particular, antibodies, fragments of antibodies and antibody-drug conjugates for industrial and scientific use; antibodies, fragments of antibodies and antibody-drug conjugates for the development or manufacture of therapeutic reagents for industrial and scientific use; biological preparations, in particular, antibodies, fragments of antibodies and antibody-drug conjugates for laboratories, diagnostics and analytics for scientific or research use; chemical, biochemical, biological, and biotechnological preparations for industrial and scientific use. |
| Goods and Services | Pharmaceutical and veterinary preparations and substances for the treatment of cancer, inflammatory diseases, autoimmune diseases, infective diseases, cardiovascular diseases, liver metabolic disorders and other conditions which can be treated or ameliorated by antibodies binding to, or activation or blocking of, a target antigen; therapeutic pharmaceuticals, namely antibody-drug conjugates for the treatment of cancer and autoimmune diseases; pharmaceutical and veterinary preparations for the treatment of cancer, inflammatory diseases, autoimmune diseases, infective diseases, cardiovascular diseases and liver metabolic disorders comprising small molecules; small molecule compounds being pharmaceuticals for the treatment of cancer |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 13, 2025 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 13, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 13, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Tubulis GmbH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 27 - NOT AVAILABLE |
| Address | DE |
| Party Name | Tubulis GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 27 - NOT AVAILABLE |
| Address | DE |
| Event Date | Event Description |
| Thursday, March 13, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Sunday, March 16, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sunday, March 16, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, July 16, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, July 16, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, July 17, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, August 20, 2025 | REFUSAL PROCESSED BY MPU |
| Thursday, August 21, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, September 5, 2025 | REFUSAL PROCESSED BY IB |
| Wednesday, February 4, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, February 4, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, February 4, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, February 13, 2026 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, February 13, 2026 | EXAMINERS AMENDMENT E-MAILED |
| Friday, February 13, 2026 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, February 13, 2026 | EXAMINER'S AMENDMENT ENTERED |
| Friday, February 13, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 4, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 10, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 10, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |